A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site

被引:0
作者
Dong-Yeop Shin
Yoon Hee Choi
Hyo-Rak Lee
Im Il Na
Young Jin Yuh
Bong-Seog Kim
Ik Joo Chung
Woo-Kyun Bae
Hyun-Jeong Shim
Eun-Kee Song
Sung Hyun Yang
Hye Jin Kang
机构
[1] Korea Institute of Radiological and Medical Sciences,Division of Hematology and Medical Oncology, Department of Internal Medicine, Korea Cancer Center Hospital
[2] Dongnam Institute of Radiological and Medical Sciences,Division of Hematology
[3] Inje University,Oncology, Department of Internal Medicine
[4] VHS Medical Center,Department of Internal Medicine, Sanggye Paik Hospital, College of Medicine
[5] Chonnam National University Hwasun Hospital,Division of Hematology
[6] Chonbuk National University Medical School,Oncology, Department of Internal Medicine
来源
Cancer Chemotherapy and Pharmacology | 2016年 / 77卷
关键词
Adenocarcinoma of unknown primary; FOLFOX; Oxaliplatin; Phase II trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:163 / 168
页数:5
相关论文
共 205 条
[1]  
Levi F(2002)Epidemiology of unknown primary tumours Eur J Cancer 38 1810-1812
[2]  
Te VC(2002)Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984–1992 Eur J Cancer 38 409-413
[3]  
Erler G(1993)Treatment of patients with cancer of an unknown primary site N Engl J Med 329 257-263
[4]  
Randimbison L(2003)Diagnostic and therapeutic management of cancer of an unknown primary Eur J Cancer 39 1990-2005
[5]  
La Vecchia C(2003)Summary of the standards, options and recommendations for the management of patients with carcinoma of unknown primary site (2002) Br J Cancer 89 S59-S66
[6]  
van de Wouw AJ(1991)Phase II trial of cisplatin for adenocarcinoma of unknown primary site. IKZ/IKO Clinical Research Group Eur J Cancer 27 755-757
[7]  
Janssen-Heijnen ML(1999)Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam) Ann Oncol 10 1389-1392
[8]  
Coebergh JW(2002)A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary site Br J Cancer 86 1238-1242
[9]  
Hillen HF(2000)Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study J Clin Oncol 18 3101-3107
[10]  
Hainsworth JD(2000)Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin Ann Oncol 11 211-215